Medicine Man Technologies Closes on Second Phase of Strategic Investment from Dye Capital & Company

Medicine Man Technologies, Inc. (OTCQX: MDCL) (“Medicine Man Technologies” or “Company”), today announced that the Company has amended its original securities purchase agreement (SPA) dated…

Medicine Man Technologies, Inc. (OTCQX: MDCL) (“Medicine Man Technologies” or “Company”), today announced that the Company has amended its original securities purchase agreement (SPA) dated June 5, 2019, with strategic partner Dye Capital & Company. Pursuant to the amendment, the SPA was revised to reflect an increase in the overall size of the funding from […]

The post Medicine Man Technologies Closes on Second Phase of Strategic Investment from Dye Capital & Company appeared first on Technical420.

Leave a Reply

Your email address will not be published. Required fields are marked *